Company News

KLUS Pharma is Attending BIO Partnering at JPM 2023!

Come meet with us at BIO Partnering at JPM 2023 to learn more about our innovative pipeline!

Image-empty-state.png

November 14, 2022

KLUS Pharma is Attending BioPharm America in Boston!

KLUS Pharma is Attending BioPharm America in Boston from September 28-29

Image-empty-state.png

September 8, 2022

Kelun-Biotech Announces Oncology Research Collaboration and License Agreement with MSD

Kelun-Biotech Announces Oncology Research Collaboration and License Agreement with MSD

Image-empty-state.png

July 26, 2022

A400/EP0031 Obtains IND Approval from FDA

Kelun-Biotech's small molecule A400/EP0031 obtained IND approval from the FDA submitted by collaboration partner Ellipses Pharma

Image-empty-state.png

June 28, 2022

Updates for A166 (HER2 ADC) will be presented at 2022 ASCO Annual Meeting

Clinical updates will be presented at 2022 ASCO for the Phase 1 dose-expansion study of A166 in HER2+ metastatic breast cancer.

Image-empty-state.png

May 29, 2022

KLUS Pharma is Attending BIO International Convention in San Diego!

KLUS Pharma will attend 2022 BIO International in San Diego from June 13-16.

Image-empty-state.png

May 15, 2022

KLUS Pharma is Attending BIO-Europe Spring 2022

KLUS Pharma will attend BIO-Europe Spring to be held virtually from March 28-31, 2022.

Image-empty-state.png

March 1, 2022

KLUS Pharma is Attending 40th Annual J.P. Morgan Health Care Conference

KLUS Pharma will attend the 40th Annual J.P. Morgan Health Care Conference to be held virtually from January 10-13, 2022

Image-empty-state.png

January 1, 2022

Kelun-Biotech Will Present an Update on SKB264 at 2021 ESMO

Kelun-Biotech will present an oral update on SKB264 at 2021 ESMO Annual Meeting held from September 16-21.

Image-empty-state.png

September 10, 2021

KLUS Pharma is Attending 2021 BioPharm America Digital Conference

KLUS Pharma will attend 2021 BioPharm America Digital Conference held from September 20-23.

Image-empty-state.png

September 10, 2021

Kelun-Biotech Will Present Updates for A166 at ASCO

Kelun-Biotech will attend and present at ASCO 2021 for A166, an anti-HER2 ADC.

Image-empty-state.png

May 20, 2021

KLUS Pharma is Attending BIO International Convention Digital Event

KLUS Pharma will attend BIO International Convention Digital 2021 from June 14-18.

Image-empty-state.png

May 20, 2021